Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-05-29

Clinical Trial Update: Olanzapine Compared to Lamotrigine in the Prevention of Depressive Episode in the Patients With Bipolar Disorder [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing olanzapine and lamotrigine for the prevention of depressive episodes in patients with bipolar disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamotrigine (lamotrigine)
  • olanzapine (olanzapine)

Snippet

Sponsor: Tri-Service General Hospital | Conditions: Bipolar Disorder | Phase 4 | Status: COMPLETED